| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Omega Therapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 75,000 | 07 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OMGAQ | Omega Therapeutics, Inc. | 07 Feb 2024 | 2 | $0 | 4 | Chief Scientific Officer | 09 Feb 2024, 17:14 |
| OMGAQ | Omega Therapeutics, Inc. | 28 Feb 2023 | 1 | $0 | 4 | Chief Scientific Officer | 02 Mar 2023, 15:05 |
| OMGAQ | Omega Therapeutics, Inc. | 27 Oct 2022 | 1 | $0 | 4 | Chief Scientific Officer | 28 Oct 2022, 18:40 |
| OMGAQ | Omega Therapeutics, Inc. | 09 Mar 2022 | 1 | $0 | 4 | Chief Scientific Officer | 11 Mar 2022, 15:05 |
| OMGAQ | Omega Therapeutics, Inc. | 29 Jul 2021 | 0 | $0 | 3 | Chief Scientific Officer | 29 Jul 2021, 21:01 |